Lantheus Holdings, Inc. (LNTH)
NASDAQ • Healthcare
Last close at September 14, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Lantheus Holdings, Inc. keeps $19 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 51 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Lantheus Holdings beat expectations on both the top and bottom line, with adjusted EPS of $1.55 topping the $1.30 estimate (+19.2%) and revenue of $388.2 million topping the $363.2 million estimate (+6.9%) for the second fiscal quarter of 2026 reported August 6, 2026. Revenue rose ~3% to about $388.2 million from about $378.0 million a year ago, with the United States remaining the clear majority of sales as revenue there grew ~3% to roughly $368.3 million while rest-of-world revenue fell ~9% to about $19.9 million. Profitability was supported by a gross margin of ~62% and an operating margin near 26%, with gross profit of roughly $241.9 million and operating income of about $100.2 million. Net income slipped ~5% to around $75.0 million (down from about $78.8 million a year earlier), and adjusted EPS of $1.55 was down from $1.57 a year ago. The company generated operating cash flow of roughly $217.3 million. For the next period, consensus calls for EPS of $1.25 on revenue of $360.4 million.
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes advanced diagnostic and therapeutic agents for medical imaging and related care. The healthcare company, listed on the NASDAQ Global Market as LNTH, sells specialty pharmaceuticals and radiopharmaceutical products, and recorded $1.5 billion of revenue in FY2025.
Today's Snapshot
The session opened with LNTH slightly higher at 100.46, in line with a flat sector.
Trading Volume
Below 10d avg (906.7K)
159.9K
vs S&P 500 Today
Moderate Outperformance
+0.47%
Updated: September 15, 2026 at 14:56 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$84.78 - $100.90Sell
- RSI (14)45.13Neutral
- Stochastic %K (14, 3, 3)15.83Buy
- MACD Level (12, 26)-0.36Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.